drugset / Trial / NCT07608770
A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat
RandomizedParallel-groupSingle-blindTreatment
Summary
A phase 2b, randomized, placebo-controlled study with long-term re-treatment to evaluate the efficacy, safety, and tolerability of CBL-514 injection for reducing abdominal subcutaneous fat
Timeline
- Start
- 2026-06
- Primary completion
- 2027-04
- Completion
- 2027-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CBL-514 | Unknown | 120 ml | Subcutaneous |
Indications
No indication recorded.